4.2 Review

Frontotemporal dementia with tau pathology

Journal

NEURODEGENERATIVE DISEASES
Volume 4, Issue 2-3, Pages 236-253

Publisher

KARGER
DOI: 10.1159/000101848

Keywords

frontotemporal dementia; FTDP-17; tau; tau mutations; neurodegeneration

Funding

  1. Alzheimers Research UK [ART-RF2005-5] Funding Source: researchfish

Ask authors/readers for more resources

Tau is a microtubule-associated protein involved in microtubule assembly and stabilization. Filamentous deposits made of tau constitute a major defining characteristic of several neurodegenerative diseases known as tauopathies including Alzheimer's disease. The involvement of tau in neurodegeneration has been clarified by the identification of genetic mutations in the tau gene in cases with familial frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Although the mechanism through which tau mutations lead to neuronal death is still unresolved, it is clear that tau mutations lead to formation of tau filaments that have a different morphology, contain different types of tau isoforms and produce distinct tau deposits. The range of tau pathology identified in FTDP-17 recapitulates the tau pathology present in sporadic tauopathies and indicates that tau dysfunction plays a major role also in these diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available